Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pesticides | 8 | 2024 | 299 | 5.180 |
Why?
|
Oxidative Stress | 34 | 2024 | 3139 | 2.910 |
Why?
|
Breast Neoplasms | 45 | 2024 | 21163 | 2.900 |
Why?
|
Nitric Oxide | 26 | 2024 | 2143 | 1.440 |
Why?
|
Glutathione Transferase | 2 | 2021 | 564 | 1.230 |
Why?
|
Antibodies, Antineutrophil Cytoplasmic | 2 | 2020 | 294 | 1.200 |
Why?
|
Brazil | 9 | 2024 | 1247 | 1.100 |
Why?
|
Occupational Exposure | 4 | 2024 | 1817 | 1.040 |
Why?
|
Oxidation-Reduction | 11 | 2024 | 2225 | 1.010 |
Why?
|
Arachidonate 5-Lipoxygenase | 2 | 2019 | 128 | 0.980 |
Why?
|
Carcinoma, Ductal, Breast | 6 | 2021 | 1094 | 0.960 |
Why?
|
Lipid Peroxidation | 16 | 2024 | 276 | 0.930 |
Why?
|
Glucuronosyltransferase | 1 | 2024 | 136 | 0.910 |
Why?
|
Receptor, erbB-2 | 7 | 2022 | 2588 | 0.870 |
Why?
|
Agriculture | 1 | 2024 | 187 | 0.830 |
Why?
|
Nitric Oxide Synthase Type II | 8 | 2020 | 515 | 0.820 |
Why?
|
Chagas Disease | 3 | 2020 | 166 | 0.820 |
Why?
|
Atrazine | 1 | 2022 | 9 | 0.820 |
Why?
|
Pesticide Residues | 1 | 2023 | 95 | 0.800 |
Why?
|
Agricultural Workers' Diseases | 1 | 2022 | 28 | 0.790 |
Why?
|
Antioxidants | 9 | 2022 | 1673 | 0.790 |
Why?
|
Proteomics | 9 | 2019 | 3906 | 0.770 |
Why?
|
Reactive Oxygen Species | 12 | 2024 | 2146 | 0.740 |
Why?
|
Leishmania | 5 | 2021 | 75 | 0.730 |
Why?
|
Water Pollutants, Chemical | 1 | 2024 | 362 | 0.700 |
Why?
|
Doxorubicin | 5 | 2021 | 2229 | 0.700 |
Why?
|
Antiprotozoal Agents | 5 | 2019 | 95 | 0.690 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 2 | 2023 | 1105 | 0.690 |
Why?
|
Trypanosoma cruzi | 6 | 2020 | 204 | 0.680 |
Why?
|
Plant Leaves | 1 | 2020 | 153 | 0.680 |
Why?
|
Inflammation Mediators | 5 | 2024 | 1891 | 0.670 |
Why?
|
NF-kappa B | 5 | 2024 | 2487 | 0.670 |
Why?
|
Paclitaxel | 5 | 2021 | 1736 | 0.670 |
Why?
|
Neoplasms | 10 | 2023 | 22389 | 0.610 |
Why?
|
Hospital Records | 1 | 2018 | 93 | 0.600 |
Why?
|
Environmental Monitoring | 1 | 2024 | 1463 | 0.590 |
Why?
|
Cytokines | 13 | 2023 | 7443 | 0.570 |
Why?
|
Interleukin-12 | 4 | 2023 | 577 | 0.560 |
Why?
|
Mass Spectrometry | 5 | 2016 | 2201 | 0.550 |
Why?
|
Peroxidase | 1 | 2020 | 609 | 0.540 |
Why?
|
Antineoplastic Agents, Phytogenic | 3 | 2017 | 622 | 0.540 |
Why?
|
Macrophages, Peritoneal | 5 | 2020 | 244 | 0.540 |
Why?
|
Leishmaniasis, Cutaneous | 4 | 2021 | 137 | 0.530 |
Why?
|
Caffeine | 1 | 2020 | 702 | 0.510 |
Why?
|
Prognosis | 17 | 2024 | 30020 | 0.490 |
Why?
|
Autoimmunity | 2 | 2020 | 1360 | 0.490 |
Why?
|
Lipid Peroxides | 4 | 2023 | 74 | 0.480 |
Why?
|
Pain, Intractable | 1 | 2015 | 132 | 0.470 |
Why?
|
Glutathione | 5 | 2024 | 585 | 0.470 |
Why?
|
Acute-Phase Proteins | 1 | 2015 | 251 | 0.470 |
Why?
|
Mammary Glands, Human | 1 | 2015 | 202 | 0.460 |
Why?
|
Gene Expression Regulation, Neoplastic | 10 | 2023 | 8628 | 0.440 |
Why?
|
Disease Susceptibility | 2 | 2020 | 1795 | 0.440 |
Why?
|
Genital Neoplasms, Female | 1 | 2018 | 538 | 0.410 |
Why?
|
Female | 70 | 2024 | 397050 | 0.400 |
Why?
|
Propolis | 3 | 2016 | 15 | 0.390 |
Why?
|
Tumor Microenvironment | 5 | 2023 | 3940 | 0.390 |
Why?
|
Adiponectin | 2 | 2014 | 1117 | 0.360 |
Why?
|
Down-Regulation | 3 | 2020 | 2937 | 0.350 |
Why?
|
Humans | 80 | 2024 | 768298 | 0.350 |
Why?
|
Metformin | 4 | 2020 | 911 | 0.340 |
Why?
|
Proteome | 3 | 2015 | 1880 | 0.340 |
Why?
|
Chagas Cardiomyopathy | 1 | 2010 | 72 | 0.340 |
Why?
|
Concanavalin A | 2 | 2020 | 190 | 0.330 |
Why?
|
Transforming Growth Factor beta | 3 | 2015 | 2003 | 0.330 |
Why?
|
Drug Resistance, Neoplasm | 6 | 2020 | 5335 | 0.330 |
Why?
|
Lipid Metabolism | 2 | 2017 | 1900 | 0.330 |
Why?
|
Tumor Necrosis Factor-alpha | 7 | 2024 | 4357 | 0.330 |
Why?
|
Models, Cardiovascular | 1 | 2014 | 984 | 0.320 |
Why?
|
Environmental Exposure | 1 | 2024 | 4528 | 0.320 |
Why?
|
Leukotrienes | 1 | 2010 | 232 | 0.320 |
Why?
|
Leishmania braziliensis | 2 | 2019 | 16 | 0.300 |
Why?
|
Multiple Myeloma | 2 | 2024 | 5192 | 0.300 |
Why?
|
Antineoplastic Agents | 8 | 2023 | 13696 | 0.300 |
Why?
|
Anti-Inflammatory Agents | 2 | 2016 | 1812 | 0.290 |
Why?
|
Transforming Growth Factor beta1 | 4 | 2020 | 637 | 0.290 |
Why?
|
Protein Carbonylation | 4 | 2015 | 28 | 0.280 |
Why?
|
Central Nervous System Neoplasms | 1 | 2016 | 930 | 0.280 |
Why?
|
Neutrophils | 1 | 2020 | 3785 | 0.280 |
Why?
|
Leishmaniasis | 2 | 2017 | 67 | 0.280 |
Why?
|
Chromatography, Liquid | 3 | 2015 | 997 | 0.280 |
Why?
|
Protein Processing, Post-Translational | 1 | 2014 | 1967 | 0.270 |
Why?
|
Breast | 1 | 2015 | 1975 | 0.270 |
Why?
|
Middle Aged | 36 | 2024 | 223463 | 0.270 |
Why?
|
Cell Line, Tumor | 14 | 2024 | 17132 | 0.260 |
Why?
|
DNA Damage | 3 | 2017 | 2459 | 0.260 |
Why?
|
Analgesics, Opioid | 1 | 2021 | 3836 | 0.250 |
Why?
|
Carcinoma, Hepatocellular | 3 | 2023 | 2331 | 0.240 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2015 | 2846 | 0.240 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2021 | 9433 | 0.240 |
Why?
|
Genetic Predisposition to Disease | 3 | 2021 | 18047 | 0.240 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 6 | 2015 | 3811 | 0.240 |
Why?
|
Malondialdehyde | 5 | 2015 | 113 | 0.240 |
Why?
|
Ruthenium Compounds | 2 | 2016 | 8 | 0.240 |
Why?
|
Ovarian Neoplasms | 1 | 2021 | 4908 | 0.230 |
Why?
|
Inflammation | 10 | 2024 | 10863 | 0.230 |
Why?
|
Neoplasm Proteins | 2 | 2015 | 3609 | 0.230 |
Why?
|
NF-E2-Related Factor 2 | 2 | 2024 | 378 | 0.220 |
Why?
|
Adult | 31 | 2024 | 223622 | 0.220 |
Why?
|
Hematocrit | 1 | 2005 | 625 | 0.220 |
Why?
|
Antibiotics, Antineoplastic | 2 | 2019 | 677 | 0.220 |
Why?
|
Peroxisome Proliferator-Activated Receptors | 1 | 2023 | 61 | 0.220 |
Why?
|
Erythrocytes | 5 | 2015 | 2421 | 0.220 |
Why?
|
Neoplasm Staging | 8 | 2023 | 11254 | 0.220 |
Why?
|
Wedelia | 1 | 2022 | 1 | 0.210 |
Why?
|
Arthritis, Gouty | 1 | 2022 | 28 | 0.210 |
Why?
|
Aldrin | 1 | 2022 | 2 | 0.210 |
Why?
|
Trifluralin | 1 | 2022 | 2 | 0.210 |
Why?
|
Diuron | 1 | 2022 | 4 | 0.210 |
Why?
|
Chlordan | 1 | 2022 | 5 | 0.210 |
Why?
|
Dieldrin | 1 | 2022 | 7 | 0.210 |
Why?
|
DDT | 1 | 2022 | 32 | 0.210 |
Why?
|
Rats, Wistar | 8 | 2022 | 1890 | 0.200 |
Why?
|
alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid | 1 | 2022 | 70 | 0.200 |
Why?
|
Interleukin-4 | 2 | 2023 | 1157 | 0.200 |
Why?
|
Cell Proliferation | 9 | 2023 | 10464 | 0.200 |
Why?
|
Signal Transduction | 12 | 2024 | 23629 | 0.200 |
Why?
|
Epigenesis, Genetic | 2 | 2021 | 3826 | 0.200 |
Why?
|
Mice, Inbred BALB C | 11 | 2021 | 6228 | 0.200 |
Why?
|
Rural Population | 2 | 2024 | 2318 | 0.200 |
Why?
|
Aged | 20 | 2024 | 171544 | 0.200 |
Why?
|
Dichlorodiphenyl Dichloroethylene | 1 | 2022 | 86 | 0.200 |
Why?
|
Liver Neoplasms | 3 | 2023 | 4360 | 0.190 |
Why?
|
Animals | 34 | 2023 | 169322 | 0.190 |
Why?
|
Lung Neoplasms | 3 | 2023 | 13576 | 0.180 |
Why?
|
Chalcone | 1 | 2020 | 10 | 0.180 |
Why?
|
Chalcones | 1 | 2020 | 32 | 0.180 |
Why?
|
Leukocytes, Mononuclear | 2 | 2018 | 1855 | 0.180 |
Why?
|
Medulla Oblongata | 1 | 2022 | 248 | 0.180 |
Why?
|
Research Report | 1 | 2023 | 369 | 0.170 |
Why?
|
Halogenation | 1 | 2020 | 46 | 0.170 |
Why?
|
Glutathione S-Transferase pi | 1 | 2020 | 99 | 0.170 |
Why?
|
DNA Modification Methylases | 1 | 2021 | 209 | 0.170 |
Why?
|
Perioperative Period | 1 | 2021 | 252 | 0.170 |
Why?
|
STAT3 Transcription Factor | 1 | 2024 | 875 | 0.170 |
Why?
|
Carcinoma | 1 | 2011 | 2340 | 0.170 |
Why?
|
Stress, Psychological | 1 | 2015 | 4543 | 0.170 |
Why?
|
Case-Control Studies | 8 | 2024 | 22292 | 0.170 |
Why?
|
Diterpenes | 2 | 2022 | 170 | 0.160 |
Why?
|
Biomarkers, Pharmacological | 1 | 2020 | 162 | 0.160 |
Why?
|
Molecular Targeted Therapy | 4 | 2020 | 2830 | 0.160 |
Why?
|
Obesity | 4 | 2017 | 13082 | 0.160 |
Why?
|
Triclosan | 1 | 2019 | 58 | 0.160 |
Why?
|
Hypertension | 5 | 2022 | 8615 | 0.160 |
Why?
|
Leishmania mexicana | 2 | 2015 | 33 | 0.160 |
Why?
|
Proteins | 1 | 2014 | 6006 | 0.160 |
Why?
|
Multiple Sclerosis, Relapsing-Remitting | 2 | 2016 | 558 | 0.160 |
Why?
|
Hematopoietic Stem Cells | 2 | 2024 | 3407 | 0.160 |
Why?
|
Quercetin | 1 | 2019 | 96 | 0.150 |
Why?
|
Sodium Glutamate | 3 | 2017 | 22 | 0.150 |
Why?
|
Ascorbic Acid | 1 | 2022 | 658 | 0.150 |
Why?
|
Tumor Escape | 1 | 2021 | 372 | 0.150 |
Why?
|
Survival Analysis | 3 | 2024 | 10117 | 0.150 |
Why?
|
Polymorphism, Single Nucleotide | 3 | 2024 | 16027 | 0.150 |
Why?
|
HIV-1 | 2 | 2015 | 6963 | 0.150 |
Why?
|
Apoptosis | 8 | 2023 | 9506 | 0.150 |
Why?
|
Pharmacogenetics | 1 | 2022 | 683 | 0.140 |
Why?
|
Axilla | 1 | 2020 | 628 | 0.140 |
Why?
|
Blotting, Western | 2 | 2015 | 5033 | 0.140 |
Why?
|
Melatonin | 1 | 2023 | 669 | 0.140 |
Why?
|
Superoxide Dismutase | 3 | 2022 | 596 | 0.140 |
Why?
|
Monoterpenes | 1 | 2017 | 22 | 0.140 |
Why?
|
1,2-Dimethylhydrazine | 1 | 2016 | 8 | 0.140 |
Why?
|
Hematopoietic Stem Cell Mobilization | 1 | 2018 | 225 | 0.140 |
Why?
|
Cell Polarity | 1 | 2020 | 640 | 0.140 |
Why?
|
Silver | 1 | 2017 | 118 | 0.140 |
Why?
|
Aberrant Crypt Foci | 1 | 2016 | 12 | 0.140 |
Why?
|
Anti-Infective Agents, Local | 1 | 2019 | 248 | 0.140 |
Why?
|
Tyrosine | 2 | 2024 | 1428 | 0.140 |
Why?
|
Nitroso Compounds | 1 | 2016 | 71 | 0.140 |
Why?
|
Bone Marrow Cells | 1 | 2024 | 2414 | 0.130 |
Why?
|
Early Detection of Cancer | 2 | 2021 | 3236 | 0.130 |
Why?
|
Sympathetic Nervous System | 2 | 2022 | 521 | 0.130 |
Why?
|
Paraneoplastic Polyneuropathy | 1 | 2015 | 2 | 0.130 |
Why?
|
Guanidines | 1 | 2017 | 194 | 0.130 |
Why?
|
Trypanocidal Agents | 1 | 2016 | 40 | 0.130 |
Why?
|
Neoplasm Invasiveness | 4 | 2020 | 3631 | 0.130 |
Why?
|
Nitrates | 2 | 2015 | 260 | 0.130 |
Why?
|
Lupus Erythematosus, Systemic | 3 | 2013 | 2171 | 0.130 |
Why?
|
Nitroprusside | 1 | 2016 | 272 | 0.130 |
Why?
|
Immunohistochemistry | 6 | 2016 | 11117 | 0.130 |
Why?
|
Gout | 1 | 2022 | 621 | 0.130 |
Why?
|
beta Catenin | 1 | 2020 | 1047 | 0.120 |
Why?
|
Uterus | 1 | 2019 | 661 | 0.120 |
Why?
|
Genes, erbB-2 | 1 | 2015 | 162 | 0.120 |
Why?
|
Prostatic Neoplasms | 1 | 2018 | 11220 | 0.120 |
Why?
|
Genetic Heterogeneity | 2 | 2015 | 737 | 0.120 |
Why?
|
Fetal Growth Retardation | 1 | 2019 | 591 | 0.120 |
Why?
|
Monitoring, Immunologic | 1 | 2015 | 100 | 0.120 |
Why?
|
Genomics | 2 | 2022 | 5916 | 0.120 |
Why?
|
Nitric Oxide Donors | 1 | 2015 | 126 | 0.120 |
Why?
|
Catalase | 2 | 2014 | 216 | 0.120 |
Why?
|
Myoblasts, Cardiac | 1 | 2014 | 21 | 0.120 |
Why?
|
Interleukin-1beta | 3 | 2015 | 1020 | 0.120 |
Why?
|
Carcinoma, Ductal | 1 | 2015 | 97 | 0.120 |
Why?
|
Chromatography, High Pressure Liquid | 2 | 2015 | 1539 | 0.120 |
Why?
|
Tumor Suppressor Protein p53 | 3 | 2020 | 2950 | 0.120 |
Why?
|
Mice | 17 | 2023 | 82004 | 0.120 |
Why?
|
Cyclooxygenase 1 | 1 | 2014 | 98 | 0.120 |
Why?
|
Cyclooxygenase 2 | 2 | 2014 | 599 | 0.120 |
Why?
|
Indomethacin | 1 | 2015 | 323 | 0.110 |
Why?
|
Vitamin D | 2 | 2020 | 3311 | 0.110 |
Why?
|
Brain Neoplasms | 1 | 2016 | 9197 | 0.110 |
Why?
|
Interleukin-17 | 1 | 2020 | 922 | 0.110 |
Why?
|
Disease Progression | 3 | 2021 | 13646 | 0.110 |
Why?
|
Ferritins | 2 | 2015 | 601 | 0.110 |
Why?
|
Melanoma, Experimental | 1 | 2017 | 559 | 0.110 |
Why?
|
Enzyme Inhibitors | 4 | 2021 | 3722 | 0.110 |
Why?
|
Acute Disease | 2 | 2017 | 7242 | 0.110 |
Why?
|
Alleles | 1 | 2024 | 6892 | 0.110 |
Why?
|
Gene Expression Profiling | 2 | 2024 | 9508 | 0.110 |
Why?
|
Multiple Sclerosis, Chronic Progressive | 1 | 2016 | 256 | 0.110 |
Why?
|
Statistics, Nonparametric | 3 | 2013 | 2862 | 0.110 |
Why?
|
Albumins | 1 | 2016 | 577 | 0.110 |
Why?
|
Metal Nanoparticles | 1 | 2017 | 405 | 0.110 |
Why?
|
Glycerol | 1 | 2014 | 274 | 0.100 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2015 | 631 | 0.100 |
Why?
|
Homocysteine | 1 | 2015 | 637 | 0.100 |
Why?
|
Maternal Exposure | 1 | 2019 | 1079 | 0.100 |
Why?
|
Drug Therapy | 1 | 2015 | 504 | 0.100 |
Why?
|
Immunomodulation | 2 | 2016 | 549 | 0.100 |
Why?
|
Thiobarbituric Acid Reactive Substances | 1 | 2011 | 45 | 0.100 |
Why?
|
Rats | 9 | 2022 | 23833 | 0.100 |
Why?
|
Metabolism, Inborn Errors | 1 | 2014 | 290 | 0.100 |
Why?
|
Oxidants | 1 | 2012 | 168 | 0.100 |
Why?
|
Transcription Factor RelA | 2 | 2024 | 254 | 0.100 |
Why?
|
Glycosylation | 1 | 2014 | 1100 | 0.100 |
Why?
|
Paracoccidioidomycosis | 1 | 2011 | 10 | 0.090 |
Why?
|
Area Under Curve | 1 | 2015 | 1642 | 0.090 |
Why?
|
Genetic Association Studies | 1 | 2021 | 2741 | 0.090 |
Why?
|
Male | 26 | 2024 | 364870 | 0.090 |
Why?
|
Nitrites | 1 | 2011 | 156 | 0.090 |
Why?
|
HIV Infections | 2 | 2015 | 17575 | 0.090 |
Why?
|
Metabolic Networks and Pathways | 1 | 2015 | 798 | 0.090 |
Why?
|
Iron | 3 | 2019 | 1815 | 0.090 |
Why?
|
Heart Rate | 5 | 2022 | 4218 | 0.090 |
Why?
|
Disease-Free Survival | 1 | 2021 | 6856 | 0.090 |
Why?
|
Cell Movement | 2 | 2020 | 5214 | 0.090 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2011 | 11854 | 0.090 |
Why?
|
In Situ Hybridization | 1 | 2014 | 1905 | 0.090 |
Why?
|
Skin | 2 | 2016 | 4499 | 0.090 |
Why?
|
Mice, Knockout | 2 | 2019 | 14481 | 0.090 |
Why?
|
Intracellular Signaling Peptides and Proteins | 2 | 2021 | 2889 | 0.080 |
Why?
|
Cardiovascular Diseases | 2 | 2014 | 15652 | 0.080 |
Why?
|
Interferon-gamma | 1 | 2018 | 3164 | 0.080 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2022 | 3666 | 0.080 |
Why?
|
Cytoskeletal Proteins | 1 | 2014 | 1337 | 0.080 |
Why?
|
High-Throughput Screening Assays | 1 | 2014 | 937 | 0.080 |
Why?
|
Th1 Cells | 1 | 2013 | 1042 | 0.080 |
Why?
|
Cyclooxygenase 2 Inhibitors | 1 | 2010 | 321 | 0.080 |
Why?
|
Th2 Cells | 1 | 2013 | 1078 | 0.070 |
Why?
|
Prospective Studies | 3 | 2021 | 54921 | 0.070 |
Why?
|
Risk Factors | 4 | 2024 | 74954 | 0.070 |
Why?
|
Cell Adhesion | 1 | 2014 | 3101 | 0.070 |
Why?
|
Heart Diseases | 1 | 2021 | 2819 | 0.070 |
Why?
|
ROC Curve | 1 | 2015 | 3622 | 0.070 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2012 | 683 | 0.070 |
Why?
|
Hepatitis C, Chronic | 1 | 2015 | 1031 | 0.070 |
Why?
|
Parasitemia | 2 | 2020 | 165 | 0.070 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2019 | 2537 | 0.070 |
Why?
|
DNA Methylation | 1 | 2021 | 4419 | 0.070 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2011 | 977 | 0.070 |
Why?
|
Endotoxemia | 1 | 2007 | 198 | 0.070 |
Why?
|
Homeostasis | 2 | 2015 | 3349 | 0.060 |
Why?
|
Cell Survival | 4 | 2017 | 5792 | 0.060 |
Why?
|
Antifungal Agents | 1 | 2011 | 757 | 0.060 |
Why?
|
Immunotherapy | 1 | 2021 | 4740 | 0.060 |
Why?
|
Aspirin | 2 | 2014 | 3136 | 0.060 |
Why?
|
Proto-Oncogene Proteins c-akt | 3 | 2023 | 2461 | 0.060 |
Why?
|
Mass Screening | 1 | 2021 | 5451 | 0.060 |
Why?
|
Genotype | 1 | 2020 | 13038 | 0.060 |
Why?
|
Diet | 1 | 2023 | 8097 | 0.060 |
Why?
|
Osmotic Pressure | 1 | 2005 | 137 | 0.060 |
Why?
|
Pulmonary Edema | 1 | 2007 | 409 | 0.060 |
Why?
|
Nitric Oxide Synthase | 1 | 2007 | 911 | 0.060 |
Why?
|
Myocardium | 3 | 2017 | 4788 | 0.060 |
Why?
|
Autonomic Nervous System | 2 | 2022 | 709 | 0.060 |
Why?
|
Clinical Trials as Topic | 1 | 2020 | 8051 | 0.060 |
Why?
|
Blood Pressure | 4 | 2022 | 8541 | 0.060 |
Why?
|
gamma-Glutamyltransferase | 2 | 2015 | 144 | 0.060 |
Why?
|
Overweight | 1 | 2015 | 2445 | 0.060 |
Why?
|
Autophagy | 2 | 2022 | 1350 | 0.050 |
Why?
|
Bone Neoplasms | 1 | 2015 | 2565 | 0.050 |
Why?
|
Cohort Studies | 3 | 2015 | 41791 | 0.050 |
Why?
|
Cell Size | 1 | 2005 | 626 | 0.050 |
Why?
|
Postmenopause | 1 | 2012 | 2518 | 0.050 |
Why?
|
Macrophages | 4 | 2021 | 5796 | 0.050 |
Why?
|
Disabled Persons | 1 | 2012 | 1215 | 0.050 |
Why?
|
Carrier Proteins | 1 | 2015 | 4940 | 0.050 |
Why?
|
Kaplan-Meier Estimate | 1 | 2013 | 6541 | 0.050 |
Why?
|
Thiohydantoins | 1 | 2022 | 19 | 0.050 |
Why?
|
Lactates | 1 | 2023 | 401 | 0.050 |
Why?
|
Bone Marrow | 1 | 2012 | 2929 | 0.050 |
Why?
|
Computer Simulation | 1 | 2015 | 6277 | 0.050 |
Why?
|
Endothelium, Vascular | 1 | 2014 | 4427 | 0.050 |
Why?
|
Fishes | 1 | 2005 | 606 | 0.050 |
Why?
|
Piperazines | 1 | 2012 | 2552 | 0.050 |
Why?
|
Receptors, Estrogen | 3 | 2015 | 2247 | 0.050 |
Why?
|
Risk Assessment | 1 | 2023 | 24316 | 0.050 |
Why?
|
Arginase | 1 | 2021 | 81 | 0.050 |
Why?
|
Dinoprostone | 2 | 2017 | 597 | 0.050 |
Why?
|
Sheep | 1 | 2023 | 1451 | 0.050 |
Why?
|
Body Mass Index | 2 | 2015 | 13050 | 0.040 |
Why?
|
Up-Regulation | 2 | 2020 | 4137 | 0.040 |
Why?
|
Histocompatibility Antigens | 1 | 2021 | 478 | 0.040 |
Why?
|
Heart | 2 | 2010 | 4449 | 0.040 |
Why?
|
Chronic Disease | 1 | 2015 | 9380 | 0.040 |
Why?
|
Phosphatidylinositol 3-Kinases | 2 | 2023 | 2884 | 0.040 |
Why?
|
Pyrimidines | 1 | 2012 | 3048 | 0.040 |
Why?
|
Ganglia, Spinal | 1 | 2022 | 530 | 0.040 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 1 | 2021 | 440 | 0.040 |
Why?
|
Predictive Value of Tests | 1 | 2016 | 15455 | 0.040 |
Why?
|
Cells, Cultured | 4 | 2018 | 19019 | 0.040 |
Why?
|
Young Adult | 3 | 2018 | 60048 | 0.040 |
Why?
|
Cyclin D1 | 1 | 2021 | 453 | 0.040 |
Why?
|
Incidence | 1 | 2018 | 21544 | 0.040 |
Why?
|
Estrous Cycle | 1 | 2019 | 65 | 0.040 |
Why?
|
Disease Models, Animal | 4 | 2014 | 18358 | 0.040 |
Why?
|
Major Histocompatibility Complex | 1 | 2021 | 877 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-fos | 1 | 2021 | 583 | 0.040 |
Why?
|
Insulin Resistance | 1 | 2013 | 3981 | 0.040 |
Why?
|
Melanoma | 1 | 2017 | 5705 | 0.040 |
Why?
|
Acetylation | 1 | 2021 | 1053 | 0.040 |
Why?
|
Anti-HIV Agents | 1 | 2014 | 4571 | 0.040 |
Why?
|
Leukapheresis | 1 | 2018 | 150 | 0.040 |
Why?
|
Liver | 4 | 2015 | 7570 | 0.040 |
Why?
|
Estrogen Receptor alpha | 1 | 2021 | 580 | 0.040 |
Why?
|
Motor Activity | 1 | 2007 | 2720 | 0.040 |
Why?
|
Uric Acid | 2 | 2014 | 806 | 0.030 |
Why?
|
Lactation | 1 | 2019 | 397 | 0.030 |
Why?
|
Phagocytes | 1 | 2018 | 294 | 0.030 |
Why?
|
Colorectal Neoplasms | 1 | 2016 | 6969 | 0.030 |
Why?
|
Nitrosation | 1 | 2016 | 25 | 0.030 |
Why?
|
Phenotype | 1 | 2014 | 16716 | 0.030 |
Why?
|
Heme Oxygenase-1 | 1 | 2019 | 365 | 0.030 |
Why?
|
Thyroid Hormones | 1 | 2019 | 407 | 0.030 |
Why?
|
Aged, 80 and over | 2 | 2020 | 59683 | 0.030 |
Why?
|
Stress, Physiological | 1 | 2023 | 1410 | 0.030 |
Why?
|
Mutation | 1 | 2020 | 30230 | 0.030 |
Why?
|
Cell Membrane | 1 | 2005 | 3663 | 0.030 |
Why?
|
Meglumine | 1 | 2015 | 144 | 0.030 |
Why?
|
NIH 3T3 Cells | 1 | 2017 | 669 | 0.030 |
Why?
|
Interferon-alpha | 1 | 2019 | 910 | 0.030 |
Why?
|
Injections, Intraperitoneal | 1 | 2015 | 413 | 0.030 |
Why?
|
Cardiovascular System | 1 | 2022 | 838 | 0.030 |
Why?
|
Transforming Growth Factor alpha | 1 | 2014 | 135 | 0.030 |
Why?
|
Aspartate Aminotransferases | 1 | 2015 | 414 | 0.030 |
Why?
|
Mice, Inbred C57BL | 3 | 2021 | 22355 | 0.030 |
Why?
|
Erythrocyte Count | 1 | 2014 | 157 | 0.030 |
Why?
|
Time Factors | 1 | 2015 | 40267 | 0.030 |
Why?
|
Fetal Development | 1 | 2019 | 771 | 0.030 |
Why?
|
Anemia | 2 | 2015 | 1520 | 0.030 |
Why?
|
NG-Nitroarginine Methyl Ester | 1 | 2014 | 262 | 0.030 |
Why?
|
Sulfhydryl Compounds | 1 | 2015 | 295 | 0.030 |
Why?
|
Interleukin-10 | 1 | 2019 | 1184 | 0.030 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2016 | 598 | 0.030 |
Why?
|
Hindlimb | 1 | 2015 | 516 | 0.030 |
Why?
|
Alanine Transaminase | 1 | 2015 | 604 | 0.030 |
Why?
|
Dinoprost | 1 | 2013 | 139 | 0.030 |
Why?
|
Sulfonamides | 2 | 2014 | 1980 | 0.030 |
Why?
|
Immunity, Cellular | 1 | 2018 | 1561 | 0.030 |
Why?
|
Immunologic Factors | 1 | 2021 | 1598 | 0.030 |
Why?
|
Lung | 3 | 2022 | 10087 | 0.020 |
Why?
|
Luminescence | 1 | 2012 | 108 | 0.020 |
Why?
|
Organometallic Compounds | 1 | 2015 | 648 | 0.020 |
Why?
|
Mediator Complex | 1 | 2012 | 106 | 0.020 |
Why?
|
Pyrazoles | 2 | 2014 | 2021 | 0.020 |
Why?
|
Paracoccidioides | 1 | 2011 | 3 | 0.020 |
Why?
|
C-Reactive Protein | 2 | 2015 | 3859 | 0.020 |
Why?
|
Multivariate Analysis | 2 | 2015 | 12092 | 0.020 |
Why?
|
Rodent Diseases | 1 | 2011 | 53 | 0.020 |
Why?
|
Neoplasms, Experimental | 1 | 2016 | 1232 | 0.020 |
Why?
|
Cell Cycle Proteins | 1 | 2023 | 3457 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2015 | 1608 | 0.020 |
Why?
|
Logistic Models | 2 | 2016 | 13323 | 0.020 |
Why?
|
Drug Synergism | 1 | 2015 | 1760 | 0.020 |
Why?
|
Nitric Oxide Synthase Type III | 1 | 2014 | 706 | 0.020 |
Why?
|
X-Rays | 1 | 2011 | 312 | 0.020 |
Why?
|
Phagocytosis | 1 | 2016 | 1530 | 0.020 |
Why?
|
Enzyme Activation | 1 | 2016 | 3585 | 0.020 |
Why?
|
Colony Count, Microbial | 1 | 2011 | 328 | 0.020 |
Why?
|
Histocytochemistry | 1 | 2011 | 699 | 0.020 |
Why?
|
Tumor Burden | 1 | 2015 | 1913 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2021 | 5800 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2020 | 4921 | 0.020 |
Why?
|
Gene Silencing | 1 | 2015 | 1501 | 0.020 |
Why?
|
Fluorescence | 1 | 2011 | 760 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2022 | 26373 | 0.020 |
Why?
|
Intensive Care Units | 1 | 2022 | 3800 | 0.020 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2014 | 1339 | 0.020 |
Why?
|
Cell Cycle | 1 | 2017 | 2934 | 0.020 |
Why?
|
Hydrogen Peroxide | 1 | 2012 | 742 | 0.020 |
Why?
|
Anthropometry | 1 | 2013 | 1343 | 0.020 |
Why?
|
Models, Statistical | 1 | 2022 | 5099 | 0.020 |
Why?
|
Hemoglobins | 1 | 2014 | 1532 | 0.020 |
Why?
|
Comorbidity | 1 | 2022 | 10588 | 0.020 |
Why?
|
Blood | 1 | 2010 | 597 | 0.020 |
Why?
|
Pain | 1 | 2022 | 5102 | 0.020 |
Why?
|
Follow-Up Studies | 3 | 2014 | 39405 | 0.020 |
Why?
|
Receptors, Progesterone | 1 | 2012 | 1145 | 0.020 |
Why?
|
Nitric Oxide Synthase Type I | 1 | 2007 | 175 | 0.020 |
Why?
|
Administration, Oral | 1 | 2015 | 4043 | 0.020 |
Why?
|
Nuclear Proteins | 1 | 2021 | 5802 | 0.020 |
Why?
|
RNA-Binding Proteins | 1 | 2015 | 1883 | 0.020 |
Why?
|
Collagen | 1 | 2015 | 2646 | 0.020 |
Why?
|
Benzamides | 1 | 2012 | 1380 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2015 | 3436 | 0.020 |
Why?
|
Swimming | 1 | 2007 | 210 | 0.020 |
Why?
|
Vitamin D Deficiency | 1 | 2015 | 1389 | 0.020 |
Why?
|
Disability Evaluation | 1 | 2012 | 1838 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2015 | 6319 | 0.020 |
Why?
|
Fibroblasts | 1 | 2015 | 4175 | 0.010 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2014 | 2277 | 0.010 |
Why?
|
Wound Healing | 1 | 2015 | 2812 | 0.010 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2012 | 2433 | 0.010 |
Why?
|
Hospitalization | 1 | 2022 | 10844 | 0.010 |
Why?
|
Treatment Outcome | 3 | 2016 | 65365 | 0.010 |
Why?
|
Pandemics | 1 | 2022 | 8750 | 0.010 |
Why?
|
Organ Size | 1 | 2007 | 2268 | 0.010 |
Why?
|
Adrenal Cortex Hormones | 1 | 2011 | 1890 | 0.010 |
Why?
|
Immunity, Innate | 1 | 2014 | 3079 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2014 | 10776 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2016 | 13019 | 0.010 |
Why?
|
Cell Line | 1 | 2014 | 15593 | 0.010 |
Why?
|
Survival Rate | 1 | 2014 | 12870 | 0.010 |
Why?
|
Lipopolysaccharides | 1 | 2007 | 2215 | 0.010 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2018 | 5711 | 0.010 |
Why?
|
Blood Glucose | 1 | 2013 | 6430 | 0.010 |
Why?
|
Insulin | 1 | 2013 | 6608 | 0.010 |
Why?
|
Sex Factors | 1 | 2013 | 10656 | 0.010 |
Why?
|
Public Health | 1 | 2011 | 2681 | 0.010 |
Why?
|
Adipose Tissue | 1 | 2010 | 3334 | 0.010 |
Why?
|
Pregnancy | 1 | 2019 | 30198 | 0.010 |
Why?
|
Body Weight | 1 | 2007 | 4630 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2018 | 81768 | 0.010 |
Why?
|
Age Factors | 1 | 2013 | 18472 | 0.010 |
Why?
|
Protein Kinase Inhibitors | 1 | 2012 | 5707 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2012 | 15939 | 0.010 |
Why?
|